CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma
Timo A. Auer,Lukas Müller,Daniel Schulze,Melina Anhamm,Dominik Bettinger,Verena Steinle,Johannes Haubold,David Zopfs,Daniel Pinto dos Santos,Michel Eisenblätter,Bernhard Gebauer,Roman Kloeckner,Federico Collettini
DOI: https://doi.org/10.1148/radiol.232044
IF: 19.7
2024-02-07
Radiology
Abstract:Background CT-guided high-dose-rate (HDR) brachytherapy (hereafter, HDR brachytherapy) has been shown to be safe and effective for patients with unresectable hepatocellular carcinoma (HCC), but studies comparing this therapy with other local-regional therapies are scarce. Purpose To compare patient outcomes of HDR brachytherapy and transarterial chemoembolization (TACE) in patients with unresectable HCC. Materials and Methods This multi-institutional retrospective study included consecutive...
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?